The Recombinant Polyclonal Drug Candidate GIGA-2339 for Hepatitis B Treatment

How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing

Palbociclib Combination Yields PFS Improvement in HR+, HER2+ Breast Cancer

AbbVie Acquires Nimble Therapeutics in $200 Million Deal to Strengthen Immunology Pipeline

OlympiA Trial: Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2- Breast Cancer

Imlunestrant Shows Promising Results Alone and with Verzenio in ER+, HER2- Breast Cancer

Elevation Oncology Partners with Synaffix in $368M Deal to Advance HER3 ADC Development

General Inception Acquires Enable Medicine to Drive AI-Led Drug Discovery Breakthroughs

Ribociclib Shows Promising Long-Term Benefits in Early Breast Cancer Treatment

IL-15 Agonist NKTR-255 Enhances CAR-T Therapy Effectiveness in LB-Cell Lymphoma

FDA Grants Breakthrough Status to Datopotamab Deruxtecan for EGFR-Mutated Lung Cancer

Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA

Blenrep Combination Reduces Death Risk by 42% in Relapsed Multiple Myeloma

Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL

Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia

Durvalumab Granted FDA Priority Review for Muscle-Invasive Bladder Cancer Patients

Promising Sac-TMT Receives FDA Breakthrough Therapy Designation for Lung Cancer

AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors

FDA Approves Durvalumab as the First and Only Immunotherapy for LSSC Lung Cancer

FDA Grants Accelerated Approval to Bizengri for Treating NRG1+ Pancreatic Cancer and NSCLC

AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer

Roche Acquires Poseida in $1.5 Billion Deal to Advance Cell Therapy Innovation

How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment

The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia

SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer

How Novel Immunotherapy IMNN-001 Could Change Ovarian Cancer Outcomes

FDA Greenlights Revumenib for Relapsed Leukemia Treatment

FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer

How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment

How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment